Dutasteride for spinal and bulbar muscular atrophy

The Lancet Neurology

Volumn 10, Issue 2, 2011, Pages 113-115

  Banno, Haruhiko ^a,b   Katsuno, Masahisa ^a,b   Suzuki, Keisuke ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DUTASTERIDE; PLACEBO;

DRUG EFFICACY; DRUG SAFETY; FALLING; HUMAN; KENNEDY DISEASE; LETTER; MUSCLE WEAKNESS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE;

ANIMALS; AZASTEROIDS; BULBO-SPINAL ATROPHY, X-LINKED; HUMANS; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 78751570904     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70324-0     Document Type: Letter

References (10)

1. Kennedy WR, Alter M, Sung JH Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968, 18:671-680.
2. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989, 112:209-232.
3. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
4. Orr HT, Zoghbi HY Trinucleotide repeat disorders. Annu Rev Neurosci 2007, 30:575-621.
5. Katsuno M, Adachi H, Kume A, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002, 35:843-854.
6. Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 2002, 59:770-772.
7. Katsuno M, Adachi H, Doyu M, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 2003, 9:768-773.
8. Banno H, Katsuno M, Suzuki K, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 2009, 65:140-150.
9. Fernández-Rhodes LE, Kokkinis AD, White MJ, et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 2011, published online Jan 7. 10.1016/S1474-4422(10)70321-5.
10. Katsuno M, Banno H, Suzuki K, et al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010, 9:875-884.